G. Reisbach

1.3k total citations
26 papers, 1.1k citations indexed

About

G. Reisbach is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, G. Reisbach has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Immunology and 7 papers in Hematology. Recurrent topics in G. Reisbach's work include Hematopoietic Stem Cell Transplantation (6 papers), Virus-based gene therapy research (4 papers) and Viral-associated cancers and disorders (4 papers). G. Reisbach is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Virus-based gene therapy research (4 papers) and Viral-associated cancers and disorders (4 papers). G. Reisbach collaborates with scholars based in Germany, Switzerland and United States. G. Reisbach's co-authors include Peter G. Dormer, Wolfgang Hammerschmidt, Reinhard Zeidler, Lothar Hültner, Karin Thalmeier, Wassilios G. Meissner, Robert A.J. Oostendorp, Henri‐Jacques Delecluse, Sibille Humme and Stephan Lang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

G. Reisbach

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Reisbach Germany 16 511 458 258 174 173 26 1.1k
R J Armitage Canada 8 325 0.6× 835 1.8× 202 0.8× 105 0.6× 137 0.8× 8 1.1k
Ronald R. Nepomuceno United States 15 281 0.5× 454 1.0× 270 1.0× 95 0.5× 330 1.9× 20 1.1k
H Mizoguchi Japan 17 506 1.0× 602 1.3× 345 1.3× 89 0.5× 83 0.5× 54 1.4k
HJ Gruss Germany 13 321 0.6× 863 1.9× 349 1.4× 354 2.0× 102 0.6× 17 1.4k
Joan de Jong Netherlands 10 372 0.7× 1.0k 2.2× 494 1.9× 112 0.6× 188 1.1× 12 1.5k
John O. Richards United States 16 477 0.9× 638 1.4× 423 1.6× 87 0.5× 121 0.7× 32 1.4k
Franz Karlhofer Austria 16 515 1.0× 1.4k 3.1× 225 0.9× 236 1.4× 129 0.7× 31 2.0k
Mark W. Brunvand United States 15 293 0.6× 554 1.2× 375 1.5× 176 1.0× 86 0.5× 22 1.2k
Nadja Prang Germany 17 837 1.6× 448 1.0× 269 1.0× 234 1.3× 126 0.7× 23 1.2k
Silvio Roncella Italy 24 621 1.2× 651 1.4× 524 2.0× 615 3.5× 131 0.8× 87 1.9k

Countries citing papers authored by G. Reisbach

Since Specialization
Citations

This map shows the geographic impact of G. Reisbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Reisbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Reisbach more than expected).

Fields of papers citing papers by G. Reisbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Reisbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Reisbach. The network helps show where G. Reisbach may publish in the future.

Co-authorship network of co-authors of G. Reisbach

This figure shows the co-authorship network connecting the top 25 collaborators of G. Reisbach. A scholar is included among the top collaborators of G. Reisbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Reisbach. G. Reisbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mautner, Josef, G. Reisbach, Falk Nimmerjahn, et al.. (2005). Epstein–Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination. Gene Therapy. 13(2). 150–162. 19 indexed citations
3.
Humme, Sibille, G. Reisbach, Regina Feederle, et al.. (2003). The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proceedings of the National Academy of Sciences. 100(19). 10989–10994. 159 indexed citations
4.
Zeidler, Reinhard, G. Reisbach, Barbara Wollenberg, et al.. (1999). Simultaneous Activation of T Cells and Accessory Cells by a New Class of Intact Bispecific Antibody Results in Efficient Tumor Cell Killing. The Journal of Immunology. 163(3). 1246–1252. 152 indexed citations
5.
Weimann, Edda, Stefan Rutkowski, & G. Reisbach. (1998). G-CSF, GM-CSF and IL-6 levels in cord blood: Diminished increase of G-CSF and IL-6 in preterms with perinatal infection compared to term neonates. Journal of Perinatal Medicine. 26(3). 211–218. 26 indexed citations
6.
Eißner, Günther, et al.. (1997). Differential modulation of IL‐1‐induced endothelial adhesion molecules and transendothelial migration of granulocytes by G‐CSF. British Journal of Haematology. 97(4). 726–733. 9 indexed citations
7.
Oostendorp, Robert A.J., et al.. (1997). Antibodies to the beta 1-integrin chain, CD44, or ICAM-3 stimulate adhesion of blast colony-forming cells and may inhibit their growth.. PubMed. 25(4). 345–9. 23 indexed citations
8.
9.
Weimann, Edda, G. Reisbach, J. Reinsberg, & M. J. Lentze. (1995). IL-6 and G-CSF levels in amniotic fluid during the second trimester in normal and abnormal pregnancies. Archives of Gynecology and Obstetrics. 256(3). 125–130. 7 indexed citations
10.
Oostendorp, Robert A.J., et al.. (1995). VLA‐4 and VCAM‐1 are the principal adhesion molecules involved in the interaction between blast colony‐forming cells and bone marrow stromal cells. British Journal of Haematology. 91(2). 275–284. 60 indexed citations
11.
Denzlinger, Claudio, et al.. (1995). [54-year-old patient with anemia, jaundice, hepatosplenomegaly and paravertebral space-occupying lesions].. PubMed. 36(7). 726–9. 1 indexed citations
12.
Denzlinger, Claudio, et al.. (1994). Granulocyte colony‐stimulating factor inhibits the endogenous leukotriene production in tumour patients. British Journal of Haematology. 86(4). 881–882. 13 indexed citations
13.
Egger, Denise, G. Reisbach, & Lothar Hültner. (1994). Simultaneous determination of histamine and serotonin in mast cells by high-performance liquid chromatography. PubMed. 662(1). 103–107. 17 indexed citations
14.
Thalmeier, Karin, et al.. (1994). Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity. Blood. 83(7). 1799–1807. 86 indexed citations
15.
Haunschild, Jutta, et al.. (1993). Mitogenicity of anti‐Thy‐1 monoclonal antibodies attributable to an Fc‐dependent mechanism. European Journal of Immunology. 23(10). 2649–2654. 4 indexed citations
16.
Reisbach, G., Ilse Bartke, Bettina Kempkes, et al.. (1993). Characterization of hemopoietic cell populations from human cord blood expressing c-kit.. PubMed. 21(1). 74–9. 42 indexed citations
17.
Reisbach, G., et al.. (1992). B‐cell chronic lymphocytic leukaemia cells express and release transforming growth factor‐β. British Journal of Haematology. 80(4). 480–487. 44 indexed citations
18.
Reisbach, G., Joachim W. Ellwart, & Peter G. Dormer. (1990). Lactate production and amino acid incorporation in interleukin 3-dependent, factor-deprived hemopoietic murine cell lines. Experimental Cell Research. 190(2). 175–178. 2 indexed citations
19.
Reisbach, G., et al.. (1987). Macrophage colony-stimulating activity is produced by three different EBV-transformed lymphoblastoid cell lines. Cellular Immunology. 109(1). 246–254. 3 indexed citations
20.
Reisbach, G., E. Gebhart, & Relda Cailleau. (1982). Sister chromatid exchanges and proliferation kinetics of human metastatic breast tumor cells lines.. PubMed. 2(4). 257–60. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R J Armitage Breakdown of academic impact, for papers by Ronald R. Nepomuceno Breakdown of academic impact, for papers by H Mizoguchi Breakdown of academic impact, for papers by HJ Gruss Breakdown of academic impact, for papers by Joan de Jong Breakdown of academic impact, for papers by John O. Richards Breakdown of academic impact, for papers by Franz Karlhofer Breakdown of academic impact, for papers by Mark W. Brunvand Breakdown of academic impact, for papers by Nadja Prang Breakdown of academic impact, for papers by Silvio Roncella
Rankless by CCL
2026